Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - steven+dubinett
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Gene-Modified Conventional Type 1 Dendritic Cells (UCLA Case No. 2026-093)
Details available soon. Please contact UCLA Technology Development Group if you have any questions or would like more information in the meantime.
Published: 3/4/2026
|
Inventor(s):
Steven Dubinett
Keywords(s):
Category(s):
Therapeutics > Immunology And Immunotherapy
Combination Immunotherapy (UCLA Case No. 2015-348)
Combination ImmunotherapySUMMARYUCLA researchers have developed a combination immunotherapy for lung cancer that functions by evoking anti-tumor immune responses in lung cancer patients.BACKGROUNDLung cancer is a challenging health problem, claiming more than 1.1 million deaths worldwide annually. Despite incredible medical progress, the long-term survival...
Published: 12/2/2025
|
Inventor(s):
Jay Lee
,
Steven Dubinett
,
Sherven Sharma
Keywords(s):
Immunotherapy
,
Oncology Immunotherapy
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Oncology > Oncology Immunotherapy